DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Jurczak W, Chojnowski K, Mayer J. , et al.
Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia.
Br J Haematol 2018
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.